Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Heng Du, B.M., M.D.

Concepts (82)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Heng Du's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Heng Du has written about over time.
Lymphangioleiomyomatosis, 2 publications between 2016 and 2018, average publication date August 2017. Tuberous Sclerosis, 3 publications between 2016 and 2019, average publication date April 2018. Angiomyolipoma, 3 publications between 2016 and 2020, average publication date September 2018. Forkhead Transcription Factors, 1 publications between 2018 and 2018, average publication date December 2018. Hemangiopericytoma, 1 publications between 2018 and 2018, average publication date December 2018. Seizures, 1 publications between 2018 and 2018, average publication date December 2018. Vimentin, 1 publications between 2018 and 2018, average publication date December 2018. Cysteine-Rich Protein 61, 1 publications between 2020 and 2020, average publication date October 2020. Inhibitor of Differentiation Protein 2, 1 publications between 2020 and 2020, average publication date October 2020. Microphthalmia-Associated Transcription Factor, 1 publications between 2020 and 2020, average publication date October 2020. Serine, 1 publications between 2021 and 2021, average publication date September 2021. Transaminases, 1 publications between 2021 and 2021, average publication date September 2021. Albumins, 1 publications between 2021 and 2021, average publication date October 2021. Perivascular Epithelioid Cell Neoplasms, 1 publications between 2021 and 2021, average publication date October 2021. Sirolimus, 2 publications between 2021 and 2023, average publication date October 2022. Tumor Escape, 1 publications between 2023 and 2023, average publication date March 2023. Phosphatidylinositol 3-Kinases, 1 publications between 2023 and 2023, average publication date October 2023.

To see the data from this visualization as text, click here.
Du's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (32)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.